IRIS International (IRIS) Stock Price, News & Analysis

Company Overview

Mitcham Industries, Inc. is a provider of equipment to the geophysical, oceanographic and hydrographic industries. The Company operates through two segments. The Equipment Leasing segment is primarily engaged in the leasing of seismic equipment to companies in the oil and gas industry across the world. The Equipment Manufacturing and Sales segment is engaged in the design, production and sale of marine seismic equipment, and oceanographic and hydrographic equipment. Its leasing business includes Mitcham Canada ULC, Seismic Asia Pacific Pty Ltd., Mitcham Seismic Eurasia LLC, Mitcham Europe Ltd. and Mitcham Marine Leasing Pte. Ltd. The Equipment Manufacturing and Sales Segment includes its Seamap International Holdings Pte, Ltd. (Seamap) business and Klein Marine Systems, Inc. (Klein). Seamap designs, manufactures and sells a range of products for the seismic, hydrographic and offshore industries. Klein develops and manufactures high performance side scan sonar systems.

Key Stats

• Today's Range: $3.40 to $3.70
• 50-Day Range: N/A
• 52-Week Range: $8.50 to $19.97
• Volume: 9,640 shs
• Average Volume: 312,442 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

IRIS Stock Analysis - Frequently Asked Questions

How were IRIS International's earnings last quarter?

IRIS International Inc (NASDAQ:IRIS) released its quarterly earnings results on Wednesday, September, 7th. The scientific and technical instruments company reported ($0.80) EPS for the quarter, missing analysts' consensus estimates of ($0.49) by $0.31. The scientific and technical instruments company earned $8.70 million during the quarter, compared to analyst estimates of $11.20 million.

What other stocks do shareholders of IRIS International own?

Based on aggregate information from My MarketBeat watchlists, some other companies that IRIS International investors own include Biocept (BIOC), Allena Pharmaceuticals (ALNA), Palatin Technologies (PTN), Weatherford International (WFT), Arbutus Biopharma (ABUS), AcelRx Pharmaceuticals (ACRX) and Ampio Pharmaceuticals (AMPE).

Company Calendar

• Last Earnings: 9/07/2016
• Today: 6/03/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: Oil & Gas Equipment & Services
• Current Symbol: NASDAQ:IRIS
• CIK: 319240
• Web: www.proiris.com
• Phone: +1-818-5277000
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A